Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0016
+0.0001 (8.11%)
Feb 12, 2026, 3:18 PM EST
Regen BioPharma Market Cap
Regen BioPharma has a market cap or net worth of $206.31 thousand as of February 13, 2026. Its market cap has decreased by -86.33% in one year.
Market Cap
206.31K
Enterprise Value
1.34M
Revenue
236.56K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 4, 2014, Regen BioPharma's market cap has decreased from 19.72M to 206.31K, a decrease of -98.95%. That is a compound annual growth rate of -32.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 217.36K | -72.82% |
| Dec 31, 2025 | 799.61K | -47.23% |
| Dec 31, 2024 | 1.52M | -57.47% |
| Dec 29, 2023 | 3.56M | -81.90% |
| Dec 30, 2022 | 19.69M | -70.55% |
| Dec 31, 2021 | 66.86M | 9,040.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 631.21K |
| Bio-Path Holdings | 609.98K |
| Helix BioMedix | 606.71K |
| Innovation Pharmaceuticals | 528.77K |
| Regenerative Medical Technology Group | 515.05K |
| Oncology Pharma | 501.98K |
| Hepion Pharmaceuticals | 429.95K |
| Actavia Life Sciences | 385.91K |